Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Upper respiratory tract immunity.

Adrian W Zuercher1

  • 1Research Immunology, Berna Biotech Ltd, Bern, Switzerland. adrian.zuercher@bernabiotech.com

Viral Immunology
|October 30, 2003
PubMed
Summary

Developing effective mucosal vaccines requires understanding the immune system at mucosal surfaces. Nasal vaccines show promise for improving respiratory pathogen protection by inducing mucosal immunity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intravenous immunoglobulin (IVIG) promotes brain repair and improves cognitive outcomes after traumatic brain injury in a FcγRIIB receptor-dependent manner.

Brain, behavior, and immunity·2022
Same author

A novel soluble complement receptor 1 fragment with enhanced therapeutic potential.

The Journal of biological chemistry·2020
Same author

Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-μTP-L309C, a recombinant IgG1 Fc hexamer.

BMC immunology·2019
Same author

Treating murine inflammatory diseases with an anti-erythrocyte antibody.

Science translational medicine·2019
Same author

Next-generation Fc receptor-targeting biologics for autoimmune diseases.

Autoimmunity reviews·2019
Same author

Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates.

Respiratory research·2019

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • Viral infections often target mucosal surfaces, necessitating robust mucosal immunity for defense.
  • Current parenteral vaccines for respiratory pathogens lack significant mucosal immune induction.
  • Understanding mucosal immune mechanisms is crucial for developing effective vaccines.

Purpose of the Study:

  • To review recent findings on the upper respiratory tract's mucosal immune system.
  • To explore cross-immunization routes between mucosal compartments for vaccine development.
  • To outline critical factors for rational nasal vaccine design.

Main Methods:

  • Review of current literature on mucosal immunology and vaccine development.
  • Focus on the nasal route for vaccine application and immune induction.
  • Analysis of preclinical and clinical developments in nasal vaccine research.

Main Results:

  • The mucosal immune system plays a vital role in defending against infections at various body surfaces.
  • Nasal vaccine strategies offer a potential route to induce significant mucosal immunity against respiratory pathogens.
  • Factors such as dose, application form, and adjuvants critically influence mucosal immunity.

Conclusions:

  • Effective mucosal vaccines, particularly for respiratory infections, require a deeper understanding of mucosal immunity.
  • Nasal vaccination presents a promising strategy for enhancing vaccine efficacy by inducing both mucosal and systemic immunity.
  • Further research into rational design and preclinical/clinical development is essential for advancing mucosal vaccines.

Related Experiment Videos